Top compounds associated with response to SPRY4


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC 0.079 0.3
mRNA thapsigargin gCSI pan-cancer AAC -0.076 0.3
mRNA Irinotecan gCSI pan-cancer AAC -0.058 0.4
mRNA Doxorubicin gCSI pan-cancer AAC -0.046 0.5
mRNA bid1870 gCSI pan-cancer AAC 0.044 0.5
mRNA Gemcitabine gCSI pan-cancer AAC 0.032 0.6
Download CSV